| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |